Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2023-03-20 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES ORAL PRESENTATION OF TRANSLATIONAL DATA FOR CS5001, A POTENTIALLY BEST-IN-CLASS ROR1-TARGETING ADC, AT THE 13TH WORLD ADC LONDON CONFERENCE
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by CStone Pharmaceuticals about the oral presentation of translational data for their drug candidate CS5001 at a scientific conference. It discusses preclinical and clinical trial progress, scientific data, and future development plans. There are no financial statements, regulatory filings, voting results, or management changes. The document is not a report but an announcement of scientific and clinical progress. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a voluntary announcement focused on clinical development and scientific data presentation, which is best classified under Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2023-03-20 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2023-03-17 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2022
Annual Report Classification · 95% confidence The document is an announcement of the annual results for the year ended December 31, 2022, including detailed financial highlights, business highlights, product launches, and commercial activities. It contains comprehensive financial data such as revenue, expenses, and loss figures, as well as non-IFRS measures. The presence of audited consolidated results and extensive financial and operational details indicates this is a full annual financial report rather than a brief earnings release or a simple announcement. The document length is 15,000 characters, which is substantial and consistent with a full report. Therefore, this document fits the definition of an Annual Report (10-K equivalent) rather than an announcement or summary. Hence, the correct classification is Annual Report (10-K).
2023-03-15 English
PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION
Regulatory Filings Classification · 95% confidence The document is an announcement regarding proposed amendments to the company's Memorandum and Articles of Association, which are subject to shareholder approval at the forthcoming AGM. It references compliance with Listing Rules and the need for shareholder resolution but does not contain financial data, detailed management discussion, or full report content. The document is relatively short (3973 characters) and serves as a notification of proposed governance changes rather than the actual governance report or AGM materials. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a formal announcement related to governance but not the full governance report or AGM presentation itself.
2023-03-15 English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE
Governance Information Classification · 95% confidence The document is titled 'Terms of Reference of the Audit Committee' and details the constitution, membership, duties, authority, and procedures of the Audit Committee of CStone Pharmaceuticals. It does not contain any financial statements, audit results, or financial performance data. Instead, it outlines governance and procedural rules related to the audit committee's role and responsibilities. This type of document is a governance-related report focusing on internal rules and committee duties rather than an audit report or annual report. Therefore, it fits best under Governance Information (CGR). The document length is substantial and contains detailed governance content, confirming it is not a brief announcement or certification.
2023-03-15 English
TERMS OF REFERENCE OF THE COMPENSATION COMMITTEE
Remuneration Information Classification · 95% confidence The document is titled 'Terms of Reference of the Compensation Committee' and details the committee's structure, membership, duties, authority, and procedures related to remuneration of directors and senior management. It does not contain financial statements, earnings data, or regulatory filings but rather governance-related content about compensation policies and committee operations. This aligns with a Remuneration Information report, which focuses on executive and director compensation details and committee terms. The document is comprehensive and not a brief announcement or certification, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the appropriate classification is Remuneration Information (DEF 14A).
2023-03-15 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.